Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa-cel
January 30, 2023Business Services
London, UK and ZUG, Switzerland, January 27, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (NASDAQ: CRSP) today announced that …
BEXIMCO PHARMACEUTICALS LIMITED Half Year Results 2022-23
January 30, 2023Business Services
Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic …
Kelso Pharma announces first product launch
January 30, 2023Business Services
30th January 2023: Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the …
Pharmacists say England is not yet unlocking potential of self-care, with 77% backing the idea of a National Self-Care Strategy
January 30, 2023Business Services
London, 30 January 2023. Today, a new report by Sanofi, an innovative global healthcare company, calls on the Government to …
Pfizer denies purposely mutating COVID-19 virus
January 30, 2023Medical Communications
Big Pharma company Pfizer has publicly denied allegations that it is deliberately mutating the COVID-19 virus in order to develop …
FDA suggests individual risk assessments for blood donations to secure US blood supply
January 30, 2023Medical Communications
The FDA has announced that it is suggesting a change from the time-based deferrals for blood donation to an individual …
Researchers develop test to predict Alzheimer’s disease years before diagnosis
January 30, 2023Medical Communications
Researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have developed a blood test which can potentially …
Chiesi Farmaceutici hires new CEO after $1.48bn Amryst acquisition
January 30, 2023Business Services
Chiesi Farmaceutici, a family-owned Italian pharmaceutical company, has appointed Giuseppe Accogli as group CEO. This comes after 2020’s $1.48bn acquisition …
FDA refuses to regulate CBD, calling on Congress to take charge
January 27, 2023Medical Communications
The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). …
FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants
January 27, 2023Medical Communications
The FDA has revoked its approval of AstraZeneca’s Evusheld due to the fact that it is not effective against more …
Ipsen reports CHMP negative review for use of palovarotene in EU
January 27, 2023Research and Development
Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …
IsoChemiX develop molecules to speed up R&D process
January 27, 2023Research and Development
UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and …
AI finds liver cancer drug candidate in only 30 days
January 26, 2023Research and Development
With most drug discovery and development processes taking years, if not decades, a team of scientists have broken records with …
Merck’s London research hub to begin construction in April 2023
January 26, 2023Business Services
Merck has been planning a $1.3bn, 220,000 square foot research hub in London for six years but will finally begin …
iNtRON confirms efficacy of ‘Inhalation Anthrax’-fighting drug
January 26, 2023Medical Communications
iNtRON, a bio-new drug developing venture company, has announced the completion of an efficacy evaluation study of BAL200. It has …
Cell BioEngines announces exclusive licencing agreement for cancer cure
January 26, 2023Medical Communications
US-based cell and gene therapy company Cell BioEngines has announced its exclusive licencing agreement with Icahn School of Medicine at …
t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells
January 26, 2023Business Services
26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it …
Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease
January 26, 2023Business Services
26 January 2023 Galway, Ireland – Orbsen Therapeutics Limited (“Orbsen”), a global leader in stromal cell immunotherapies, today announces encouraging …
First CAR T-cell therapy recommended for routine use on the NHS in England
January 26, 2023Business Services
26th JANUARY 2023, LONDON, UK – Gilead Sciences Ltd. and Kite, a Gilead company, today announced that the National Institute …
Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases
January 26, 2023Business Services
Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
